Joint Strategic Needs Assessments (JSNAs) are assessments of the current and future health and social care needs of the local community. Such needs could be met by the Local Authority, Clinical Commissioning Groups (CCGs), or the NHS boards. JSNAs are produced by Health and wellbeing boards and are unique to each local area.
The JSNA provides a single, agreed view of priorities at place level and provide crucial insight to shape the Joint Health and Wellbeing Strategy (JHWS) of the borough. Health and care partners must have regard to the JSNA and JHWS. Other related reports include the pharmaceutical needs assessment and comprehensive needs assessment.
The Havering JSNA Profile
The Havering JSNA is part of the BHR JSNA set of profiles jointly produced with colleagues in Barking and Dagenham and Redbridge Local Authorities. It is consistent with the Population Health Management approach, describing the factors shaping health outcomes for the local population in terms of the ‘four pillars of population health’, namely; a The Wider Determinants of Health, Behaviours & Lifestyles, The Places & Communities in Which We Live and Integrated Health & Social Care. A full report including an interactive version can be accessed HERE.
Pharmaceutical Needs Assessment (PNA)
Every Health and Wellbeing Board (HWB) in England has a statutory responsibility to publish and keep up to date a statement of needs for pharmaceutical services for their population. This is called the Pharmaceutical Needs Assessment (PNA) (NHS Pharmaceutical Regulations 2013).
The main user of the PNA is NHS England who commission community pharmacy services and its prime purpose is to control market entry of new pharmacies to an area over a three year period. If there are significant unplanned changes during that time then the HWB are responsible for publishing supplementary reports as required.
The HWB delegates to the Director of Public Health the responsibility of overseeing the production of the PNA on its behalf. The delivery of the PNA is then coordinated by a steering group who also quality assure the process and any decisions.
The current PNA assessed whether the current and future pharmacy provision meets the health and wellbeing needs of the Havering population. It has also determined whether there are any gaps, or need for improvements or better access, in the provision of pharmaceutical service either now or within the lifetime of this document, 1st October 2022 to 30th September 2025.
PNA Supplementary Statements 2022-2025
A Supplementary Statement highlights changes to the provision of pharmacy services since the publication of the Pharmaceutical Needs Assessment. Supplementary Statements are issued for opening, mergers or closure of pharmacies or when there are pharmaceutical needs assessment changes that are minor but would be relevant for granting of applications. Once issued, a supplementary statement becomes part of the PNA. Below are supplementary statements published since 2022.
Havering PNA Suppl Statement_Nov2022_BootsMarketPl_v1.1
Comprehensive Needs Assessment
The Havering JSNA is complemented by comprehensive needs assessments otherwise termed as ‘Deep Dives’ which focus on specific topics agreed by the HWB as priority. ‘Deep Dives’ include an analysis of published evidence, data from local service provision and stakeholder engagement. A final report usually highlights specific recommendations for strategy development and action.
Long COVID Needs Assessment
Long COVID is a new and evolving health condition which emerged during the COVID-19 pandemic. A large group of residents in Havering have been experiencing ongoing symptoms after acute COVID-19 infections. A health needs assessment was conducted to explore and identify the needs associated with Long COVID, what relevant services are available and what can be done locally to support residents. The full report can be accessed using the link below.
Havering Long COVID needs assessment – Final
